News
Innovation for value, the first international innovation conference at IDIBELL
On November 8, IDIBELL and ITEMAS co-organize Innovation for Value (#I4V), a conference focusing on the opportunities offered by innovation and new technologies in the healthcare field. In this event, which will take place at the Bellvitge University Hospital, speakers will also analyze the new business opportunities that arise thanks to scientific innovation and the […]
A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease
Parkinson’s disease (PD) is an old age disorder that causes a series of motor deficiencies that are characteristic. Normally, the four main symptoms are hand tremor, limb stiffness, slowness and impaired balance. With the progression of the disease, patients may also experience dementia and other neurological disorders. Since the main symptoms are due to degeneration […]
Oligodendroglial brain tumor survivors run the risk of developing long-term cognitive impairment
Recent results highlight the need to develop future therapeutic strategies to minimize the adverse effects of cancer treatment in patients with brain tumors and prolonged expected survival
The 2nd GRIN2B European Meeting brings together international experts and families suffering from this rare illness in Barcelona
The second GRIN2B European annual conference on GRINpathies, genetic defects of NMDA receptors, organized by the European Association GRIN2B, the group of Dr. Xavier Altafaj and collaborators of the Pompeu Fabra University and the Hospital Sant Joan de Déu, took place this past weekend. This meeting aims is to foster interactions between families, doctors and […]
Researchers prove the usefulness of semen miRNAs as non-invasive biomarkers for prostate cancer
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital (HUB), show the usefulness of certain molecules , the miRNAs in semen, as non-invasive biomarkers for prostate cancer. […]
David Llobet and Eva González Suárez receive AECC grants on World Cancer Research Day
The AECC has awarded 171 projects worth almost € 21M
Children’s brain recovers from stroke and acquires language abilities thanks to its plasticity
• In response to a stroke that affects the left hemisphere, children’s brains assign language functions to the right hemisphere • The study demonstrates our brain’s ability to reconnect in different ways, especially during early childhood
Three IDIBELL researchers receive “la Caixa” Banking Foundation grants to carry out pioneering research projects with great social impact
Researchers Mariona Graupera, Gabriela Jiménez Valerio and Bárbara Rivera Polo of the Bellvitge Biomedical Research Institute (IDIBELL) have been awarded three grants of the “Scholarships and Grants for Research and Innovation 2019” program of the banking Foundation “la Caixa”, which were officially announced yesterday afternoon in an event chaired by Pedro Duque, Minister of Science, […]
Discovered a molecule that regulates the development of cancer in a variety of human tumors
Researchers from IDIBELL-ICO and IJC discover that a non-coding region of the genome originates a key molecule for the proliferation of tumors in breast cancer and some types of sarcoma